TY - JOUR

T1 - Transarteriel embolisering som behandling af blødende gastroduodenale ulcera

AU - Rasmussen, Ida Roost

AU - Gögenur, Ismail

AU - Tolstrup, Mai-Britt

PY - 2019

Y1 - 2019

N2 - Upper gastrointestinal bleeding caused by an ulcer is a common condition with approximately 1,500 admissions a year. The mortality is roughly 9%, with an increased risk in elderly with multiple comorbidities. First-line treatment is endoscopic double therapy. If haemostasis is not achieved and/or repeated rebleeding occurs, the choice of treatment is transarterial embolisation (TAE) or traditional surgery. TAE has a higher rate of rebleeding than surgery, but the mortality is comparable, and TAE has fewer complications. Prophylactic TAE may reduce the rate of re-intervention in patients, who have a high risk of rebleeding.

AB - Upper gastrointestinal bleeding caused by an ulcer is a common condition with approximately 1,500 admissions a year. The mortality is roughly 9%, with an increased risk in elderly with multiple comorbidities. First-line treatment is endoscopic double therapy. If haemostasis is not achieved and/or repeated rebleeding occurs, the choice of treatment is transarterial embolisation (TAE) or traditional surgery. TAE has a higher rate of rebleeding than surgery, but the mortality is comparable, and TAE has fewer complications. Prophylactic TAE may reduce the rate of re-intervention in patients, who have a high risk of rebleeding.

KW - Aged

KW - Embolization, Therapeutic

KW - Gastrointestinal Hemorrhage/etiology

KW - Humans

KW - Peptic Ulcer Hemorrhage

KW - Recurrence

KW - Retrospective Studies

KW - Treatment Outcome

KW - Ulcer/complications

M3 - Tidsskriftartikel

C2 - 30729917

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V05180369

ER -